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Introduction
Postoperative cognitive dysfunction (POCD) represents 
a decrease of cognitive abilities (memory, learning, concen-
tration), which develops in the postoperative period after a 
variable amount of time (days or weeks).
Today, the pathogenesis of the POCD development is not 
fully known. Literature suggests multiple possible mecha-
nisms of POCD development. Certainly, the neuro-inflam-
matory effect (generated by the surgery itself) from the corti-
cal zones responsible for learning and memory, is one of the 
phenomena frequently noted in these patients [1]. Among 
POCD risk factors we find: age, intraoperative hypoxemia, in-
tensity of pain in the perioperative period, extent and length 
of surgery, number of surgical interventions, postoperative 
complications (infectious, respiratory, stroke) etc [2, 3].
POCD causes a decrease in quality of life and enhances 
1 year mortality [4]. POCD incidence is reported to be be-
tween 24 and 79% (short term) and 57% (long term) [5].
Neuroinflammatory theory
Riedel B. et al. [6] comes with a recent data analysis in 
order to understand physiopathology of POCD. So, POCD 
is a well-known syndrome, present in approximately 15% of 
patients of 60 years and older, characterized by a decrease of 
cognitive function as a consequence of anesthesia and sur-
gery.  Recent data suggests that POCD is mediated by the 
neuro-inflammatory response that is strongly related to the 
surgical intervention. Questions arise regarding the casualty 
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Abstract
Background: Postoperative cognitive dysfunction (POCD) represents a decrease of cognitive abilities (memory, learning, concentration), which develops 
in the postoperative period after a variable amount of time (days or weeks).  Today, the pathogenesis of the POCD development is not fully known. 
Literature suggests multiple possible mechanisms of POCD development. Certainly, the neuro-inflammatory effect (generated by the surgery itself) from 
the cortical zones responsible for learning and memory, is one of the phenomena frequently noted in these patients. This article is a narrative synthesis 
of literature on postoperative cognitive dysfunction – a quite spread phenomenon found in patients during postoperative care. We described suggested 
theories and the pathophysiological mechanisms involved in the development of this clinical condition. Its incidence according to different types of surgery 
is presented. We reviewed the available tools for identification and qualitative assessment of postoperative cognitive dysfunction, including biomarkers. 
Also, we discuss the risk factors for postoperative cognitive dysfunction and their role in clinical decision making process.  
Conclusions: Postoperative cognitive dysfunction is a common complication after the surgery. It occurs in frail patients or in individuals presenting general 
risk factors. It looks like there is a genetic predisposition for the development of postoperative cognitive dysfunction. Patients at risk of postoperative 
cognitive dysfunction can be identified by neurocognitive testing tools.
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Systemic inflammatory response, in combination with 
endocrinological, metabolic and immunological modifica-
tions plays an essential role in recovery and wound healing. 
Even though, all recent studies show that the inflammatory 
status is associated with negative perioperative results. There-
fore, interventions that modulate the inflammatory response, 
surgery, anesthesia and drugs may enhance the recovery 
and reduce complications. Research about wound physiol-
ogy underline the importance of genetic variability in sys-
temic inflammatory response [7]. Zhu J. et al. [8] published 
a study where he finds links between appearances of cogni-
tive dysfunction following cardiac ischemia. The study was 
performed on animal model, where direct implication of the 
neuroinflammatory step in POCD is shown.
Theory about mediators disbalance
Recent studies tend to prove the relationship between 
POCD and disbalance of mediators. Cytokines that are ac-
tivated by various factors during surgery are capable of af-
fecting memory operational system. Interleukin IL-1β is one 
of the most important mediators that leads to inflammatory 
response in the brain. IL-1β has local effects that depend on 
concentration and act on the hippocampus and memory. 
Lipopolysaccharides, one of the components of the exter-
nal membrane of gram negative bacteria are a strong trigger 
of inflammatory response. Confirmation of this data can be 
found in publications of Fidalgo A. et al. [9]. 
Anti-inflammatory cholinergic pathway is a neurohu-
moral mechanism that plays an important role in inflamma-
tory response suppression. Usage of cholinesterase inhibitors 
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raises cholinergic transmission, thus, may act as a potential 
approach for prevention of neuroinflammation. Kalb A. et al. 
[10] uses an animal model to reach results that state: intra-
operative administration of cholinesterase inhibitors leads 
to a decrease in the pro-inflammatory response and lowers 
neurodegeneration in the cortex and hippocampus. This 
combination may represent an instrument in pathogenesis of 
POCD.
Genetics’ theory
Apolipoprotein E (APOE) is a lipoprotein with small mo-
lecular weight, synthesized predominantly in the liver. Its role 
is to control cholesterol metabolism. Three types of APOE 
exist: E2, E3, E4; being encoded as alleles: e2, e3, e4 accord-
ing to Gerdes L. et al. [11]. Allele e4 is the one that correlates 
with atherosclerosis and Alzheimer. People having this allele 
have difficult rehabilitation after cerebral injury. Tardiff B. 
et al. [12] performs a study which included 65 patients after 
cardiac surgery, analyzing plasmatic concentration of APOE, 
especially allele e$, evaluates preoperative data about neuro-
psychological tests, age and educational level, and concludes 
that there is an important association between APOE e4 and 
POCD at 6 weeks distance after cardiac surgery. In 2007, 
Olney J. et al. [13] affirms that APOE allele e4 is the factor 
which predisposes to late postoperative delirium. Controver-
sial results are brought by Abildstrom H. et al. [14] in a study 
performed on 976 patients of the same age (40 years old) 
that underwent non-cardiac surgery. The conclusion states 
that POCD is not associa-ted with APOE allele e4. The same 
conclusions are reached by McDonagh D. et al. [15] that af-
firms that patients with APOE genotype do not correlate with 
POCD in non-car-diac surgery. Mathew J. et al. [16] creates 
a hypothesis which states that POCD is genetically drived as 
a result of genetic polymorphism of biological inflammatory 
regulation, cellular adhesion, coagulation, fat metabolism 
and vascular reactivity. Authors aim to monitor 37 unique 
nucleotides associated with cognitive decrease at 6 weeks 
after the surgery. Genetical variations of C-reactive protein 
and P-selectine were implied in the cognitive decrease after 
cardiac surgery. As a consequence of these genetic variations, 
patients can be placed in risk groups, and it could be useful as 
a perioperative anti-inflammatory strategy. 
If physiopathological mechanisms of POCD are open for 
new research, then the clinical aspects, through the prism of 
evidence based medicine, seem to offer a much larger picture. 
POCD in cardiac and vascular surgery
First researches made in order to prove POCD were made 
in cardiac surgery. Cerebral complications are frequent in 
cardiac surgery. Incidence of POCD in cardiac surgery varies 
between 30 and 80% during the first postoperative week and 
around 60% after several months, Rasmussen L. et al. [17]. A 
recent study performed by Toeg H. et al. [18], confirms the 
presence of POCD in 38% of cases at discharge and 19% at 
3 months after the surgery. Tournay-Jette E. et al. [19] pub-
lished results that cognitive dysfunction that appears after 
cardiac surgery has an incidence of 80.7% in elderly popula-
tion. POCD was documented after different types of surgery. 
Evered L. et al. [20] performs a study where he compares 
different types of surgeries, which were followed by POCD. 
Evered L. includes patients that underwent coronary angi-
ography with sedation, total hip replacement and coronary 
by-pass under general anesthesia. It was noticed on postop-
erative day 7, POCD is more frequently seen in patients af-
ter coronary by-pass, and after 3 months no differences were 
found between the study groups. Newman M. et al. [21] con-
cludes that ¾ of patients that underwent coronary by-pass, 
suffer from neurocognitive dysfunction at discharge, and 
about 1/3 of patients – at 6 months distance from the surgery. 
Thus, Newman M. performed another study on patients af-
ter 5 years from the surgery to evaluate POCD in long term. 
POCD incidence at 5 years after the surgery was almost the 
same as POCD incidence at discharge. POCD at discharge is 
predictive for its long term presence as well. This justifies the 
early POCD treatment. A similar study was made by Knipp 
S. et al. [22] with similar results.
Dijk D. et al. [23] as well studied POCD in patients after 
coronary by-pass surgery at 5 years distance. Many authors 
attributed cognitive decline to age modifications rather than 
a surgical event. This theory was sustained by Selnes O. et al. 
[24]. Controversial results are brought by Rosengart T. et al. 
[25] which performed a study on patients that were about 
to have surgery for coronary by-pass. No differences were 
found between control and study group. This difference be-
tween other studies and the study of Rosengart T. was ex-
plained by different evaluation methodologies and statistical 
analysis. The same affirmations we find in the study of Sweet 
J. et al. [26]. POCD was not confirmed after coronary by-pass 
surgeries.
POCD in non-cardiac surgery (minor and major)
Researches from modern medicine evaluated patients with 
non-cardiac pathologies. Such studies were performed in 1998 
by the research group ISPOCD1 which evaluated patients that 
underwent a major non-cardiac surgery, pro-ving that 26% of 
patients suffer from POCD at 1 week distance and about 10% 
– at 3 months distance. Monk T. et al.  [2] also proves POCD 
in patients that underwent major non-cardiac surgery and has 
a significant impact on 1 year mortality. Newman S. et al. [27] 
affirms that POCD during the first weeks after cardiac surgery 
is significant and its percentage increases with age. POCD at 6 
months distance is very low and could be occasionally present 
in particular cases. POCD in major non-cardiac surgery was 
studied by Dijkstra J. et al. [28]. POCD was found in the first 
postope-rative week. At 3 months distance, patients had good 
results, cases of cognitive changes are particular, and do not 
reflect the surgical factor, but other factors such as depression 
and age. 
POCD in elderly patients (minor and major surgery)
For the first time, POCD in elderly patients was described 
by Bedford in 1955 [29]. In such a way, Bedford starts a new 
trend of demonstrating, proving and researching a new 
branch of pathologies that interferes with surgery and anes-
thesia. One of the biggest studies is the ISPOCD1, made by 
Moller et al. [30] which confirms appearance of long term 
POCD in elderly patients. Major surgery is frequently as-
sociated with POCD in elderly patients. POCD after minor 
surgery is found in publications of Canet J. et al. [31]. POCD 
incidence in elderly patients after minor surgeries reaches 
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9.7%. Comparing with previous studies of Canet J. in minor 
and major surgery, it is stated that incidence of POCD in mi-
nor surgery in elderly is lower. 
MRI is used in monitoring of Alzheimer starting with 
pre-symptomatic phases in order to predict earlier the symp-
tomatic phase. Kline R. et al [32], based on MRI data of pa-
tients with Alzheimer, fried to demonstrate the hypothesis 
that surgery might have an impact on the brain structures 
with progression of dementia postoperatively. The study in-
cluded elderly patients. The obtained results showed that in 
patients that underwent surgery, in the first 5-9 months af-
ter the surgery (but no later), rates of gray matter atrophy 
increased in the cortex, hippocampus and lateral ventricle 
extended, comparing with the control group (non surgical). 
Neuro-psychological tests applied to these patients elucidated 
cognitive decrease in patients from the surgical group. Thus, 
elderly patients that underwent surgery had higher rates of 
cerebra atrophy and an increased risk of POCD. On the other 
hand, no correlation has been found between cerebral atro-
phy and patients that had mild cognitive dysfunction in the 
immediate postoperative period and with significant results 
of cognitive dysfunction later. 
POCD in middle-aged patients (minor and major sur-
gery)
POCD in patients of middle age in non-cardiac surgery 
has been studied by Johnson T. et al. [33] in 2002. POCD 
after non-cardiac surgery is associated with age, on the other 
hand, patients of middle age have a lower incidence. Thus, 
the research hypothesis appeared, and the researches ana-
lyzed 463 patients at 1 week postoperatively, and found that 
19.2% suffer from POCD. At 3 months distance, POCD has 
decreased to 6.2%. As mentioned before, Abildstrom H. et al. 
[14] studies POCD in patients of middle age and has stated 
an incidence of 11.7% of POCD.
POCD in young patients (minor and major surgery)
Monk T. et al. published data about POCD in young pa-
tients in 2008 [2]. The study aimed at identifying POCD in 
non-cardiac surgery, where patients of all ages are included. 
Authors were able to prove that POCD was found to be equal 
in young patients, middle age and elderly. Fact which contra-
dicts the ISPOCD1 study. Monk T. also affirms that recovery 
at 3 and 12 months after the surgery is better in young pa-
tients. 
POCD in pregnant (minor and major surgery)
Minor and major surgical procedures are associated with 
cognitive changes: memory loss and lack of concentration. 
If this is not diagnosed and treated promptly, this pathology 
may lead to serious consequences. The author supposes that 
POCD may appear as well after obstetrical interventions such 
as C-section and natural delivery, influencing the mother or 
the baby. Obstetrical or neonatal POCD is now fully known. 
The majority of studies performed focused on the risk factors 
such as: type of anesthesia, medication, intervention, stress 
etc. C-sections and obstetrical anesthesia are being used 
more frequently nowadays, and we can affirm that POCD 
will be found in this group of patients as well. Thus, maternal 
and child brain is subject of an increased risk of cognitive de-
crease with serious consequences. In conclusion, we can cite 
S. Ghosh [34]: “Real nature and incidence of POCD is complex 
and remains to be explored as its existence in obstetrical anes-
thesia cannot be excluded”.
Predictive and risk factors for POCD
Predictive and risk factors for POCD are not well es-
tablished, but the recent studies try to clarify this problem. 
POCD seems to be a multifactorial. These factors can be di-
vided into pre, intra and postoperative.
a) Preoperative factors – are factors that were present be-
fore surgery (genetic, APOE allele e4 theory, C-reactive pro-
tein and P-selectine).
Demographic factors (age and educational level). Age is 
one of the most controverted factors, cognitive decline is in-
evitable with age and it is difficult to draw conclusions on this 
matter (where exactly we have normal cognitive function and 
where we have a pathological decline due to hospitalization). 
Regarding educational level: patients with a higher educa-
tional level have a lower incidence of POCD.
Obtained risk factors during life time: general medical 
conditions, pain-killers, a specific disease (such as hyperten-
sion), POCD established before sugery, substance abuse, etc.
b) Intraoperative factors or stressing factors are those which 
start on the day of the surgical intervention. This group con-
tains the surgery itself, anesthesia, used pain-killes, hypoxia 
and intraoperative hypotension etc.
c) Postoperative factors are those factors that encouraged 
and maintained POCD: sedation, analgetics in the posto-
perative period, infections etc [35]), (tab. 1).
Methods of quantification and evaluation of POCD
Psychrometric tests
Appreciation of postoperative cognitive decline was made 
through a large variety of methods; large number of types of 
surgical interventions and the big variety of psychological 
tests make standardization difficult. Cognitive performance of 
each individual is different, due to educational level, neuronal 
reserve, factors that influence each patient during examina-
tion (tiredness, insomnia, stress etc). The majority of authors 
agree that cognitive performance of the patient should be 
compared only with the performance of the same patient.
Ghoneim M. et al. [47] considers that POCD may be 
diagnosed using only neuro-psychological tests. Neuro-
psychological tests have the goal to identify and quantify 
cognitive abilities. They are designed to evaluate different 
domains of cognition such as: general intellectual function, 
memory, attention, concentration, speed of processing and 
executive function. There are several tests in each domain. 
Test selection aims to identify even minor changes, it is dif-
ficult to achieve high scores at these tests. This kind of tests 
is used for patients with high intellectual level that have high 
scores at initial testing. Sometimes it is necessary to use low-
score tests for specific patients. Ghoneim M. suggests using 
several, most popular, tests for POCD appreciation. “Digit 
Span” and “Wechsler Adult Intelligence Scale – Revised Test” 
are oriented to test working memory. “Digit Symbol Substi-
tution” characterizes speed of processing of information and 
working memory. “Rey Auditory Verbal Learning Test” has 
the goal to teach verbally, revoke and reproduce. “The Stroop 
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Test” evaluates attention, concentration and executory func-
tion. “Grooved Peg Board” – manual dexterity and psychomo-
tor coordination. “The Trail Making Test” – attention, men-
tal flexibility and motor function. Also, it is recommended 
to test anxiety and depression, as these factors may lead to 
lower performance during testing. Anxiety is usually tested 
with “State Trait Anxiety Inventory”. Depression is usually 
tested with “The Beck Depression Inventory” and “Center for 
Epidemiological Studies Depression Scale”.
Carrascal Y. et al. [39] proposes a single test for POCD 
appreciation. He performs a study, enrolling 132 patients and 
uses “Paced Auditory Serial Addition Test”. Authors conclude 
that the percentage of POCD after cardiac surgery was equal 
to results of studies made using several tests. These tests are 
easy to use, they can be reproduced and they represent a 
simple and practical method of POCD testing after cardiac 
surgeries.
A Swedish study made by Jildenstal P. et al. [48] studies the 
evoked auditory potential during ophthalmological surgeries. 
Peculiarities of ophthalmologic surgeries limit application of 
a large spectrum of neuro-psychological tests; nevertheless, 
authors prove the utility of auditory evoked potential.
How neuro-psychological tests are applied
An important role in POCD appreciation is played by the 
fact how the tests are applied, the timing, number of evalua-
tions, number of tests used etc. Rasmussen et al. [17] comes 
with several recommendations regarding the design of such 
studies. We will discuss these aspects.
Table 1
Risk factors for POCD
Reference Risk factors and comments
Genetic factors and specific enzymes
Tardiff B et al. 1997 [12] Apolipoprotein allele E4
Mathew J et al. 2007 [16] C-reactive and P-selectine
Gaudet J et al. 2010 [36] MMP 9 (matrix metalloproteinase)
Rasmussen L et al.1999 [37]
Moller J et al. 1998 [30]
Johnson T et al. 2002 [33]
Monk T et al. 2008 [2]
Moritz S et al. 2008 [38]
Carrascal Y. 2005 [39]
Sanders RD et al. 2010 [40]
Advanced age
Patients older than 60 have a significant risk of long-term cognitive dysfunctions 
Increased mortality during the first postoperative year
Monk T et al. 2008 [2]
Sanders RD et al. 2010 [40]
Educational level
Johnson T et al. 2002 [33] Alcohol abuse. Interferes with effects of premedication and could lead to POCD in the 
immediate postoperative period
Bodolea C. 2010 [35] POCD present before admission
Monk T et al. 2008 [2]
Sanders RD et al. 2010 [40]
Stroke
Bodolea C. 2010 [35] Arterial hypertension
Monk T et al. 2008 [2] POCD at discharge is a risk factor for cognitive decrease at 3 months postoperatively
Surgery
Sanders RD et al. 2010 [40] Major surgery and history of surgeries in the past
Carrascal Y et al. 2005 [39]
Evered L et al. 2011 [20]
Cardiac and valvular surgeries
Olney JW et al. 2000 [13]
Culley DJ et al. 2007 [41]
Kavanagh T et al. 2012 [42]
Sanders RD et al. 2010 [40]
Type of anesthesia
Moller J et al. 1998 [30]
Browne S et al. 2003 [43]
Sanders RD, et al. 2010 [40]
Saricaoglu F et al. [44]
Hypoxia and hypotension during surgery
Sanders RD et al. 2010 [40]
Stanley T et al. 2002 [45]
Atrial fibrillation
Leiendecker J et al. 2010 [46] Migrant micro-embolism during surgical interventions
Sanders RD et al. 2010 [40] Infections and postoperative complications in the past
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Selection and application of tests
a) Objective vs. subjective tests. Neuropsychological tests 
should detect even small cognitive changes by evaluat-
ing several intellectual and personal aspects. One can use 
MCQ-blank, pencil-paper or various computed applications. 
Usually these tests require time and effort but can contain 
subjective complaints from patients. These tests are highly 
dependent on patients’ expectancies, self-respect and should 
not be implied for POCD evaluation.
b)Variability. Neuropsychological tests should be the 
same in both testing sessions, under the same circumstances, 
at the same time of the day. External exciting factors should 
be minimized, drugs that impede cognitive function should 
also be discontinued (opioids, hypnotics), also testing should 
not be performed if patient is in pain.
c) Basal Performance. Basal, preoperative, normal levels 
should be evaluated if patients experience tiredness, anxiety 
and depression while hospitalized. Rasmussen recommends 
primary evaluation to be done 1-2 weeks before surgery.
d) Exercising effect. Using the same set of tests favours 
memorizing. This way, performance is artificially improved. 
In order to exclude that, it is recommended to use parallel 
forms of these tests, re-testing with longer intervals of time 
or using a control group. 
e) Intervals between testing. Time intervals between tes-
ting depend on specific clinical situations. Tests are applied 
upon discharge or at the first postoperative control. Demo-
tivation and tiredness may lead to subestimation and lower 
levels of cognitive performances, than can easily be con-
founded with demotivation and chronic tiredness. If patients 
are not tested because of pre-existent cognitive dysfunction, 
the impossibility of testing may hide patients with cognitive 
decline and subestimate obtained data.
f) Emotional modifications and anxiety. Depression and 
anxiety lead to lower cognitive performances. Rasmussen 
recommends questionnaires that evaluate these variables. 
g) Drop-out. Drop-out means losing patients during the 
study. Patients abandon the study due to lack of interest, lack 
of time at discharge and even because of POCD itself. It is 
recommended to report drop-out, this way; these patients 
may be attributed to POCD.
Rasmussen et al. [17] recommends basic criteria of test 
selection:
1) Linguistic and cultural issues. Most of the tests are writ-
ten in English. Translating and adapting tests requires careful 
analysis and word selection according to local culture and us-
ing control groups. Patients with low intellectual levels may 
have difficulties in understanding some words. 
2) Parallel versions. Parallel versions that are used in order 
to exclude familiarization with the test may induce a cogni-
tive decline that is improperly calculated by a non-equivalent 
form of testing.
3) Sensibility. Tests with low sensibility, such as “Wechsler 
Adult Intelligence Scale” or ”Wechsler Memory Scale” are fre-
quently used for POCD evaluation but do not identify fine 
cognitive dysfunction.
4) Inferior and superior limit effect. Neuro-psychological 
tests that are difficult to achieve a minimal score, or, vice-
versa, tests that are very easy in obtaining the highest score 
lead to subestimation of obtained data.
5) Time and errors. It is preferably to use tests that can 
count the number of errors, and in case of no mistakes – that 
can take into consideration the total time of testing.
Nevertheless, POCD evaluation requires a set of tests in 
order to be able to appreciate a larger spectrum of cognitive 
functions. But it is important to have in mind the time re-
quired to perform the testing. Testing should not make the 
patient tired, because this will lead to incorrect data. Some 
authors recommend calculation of performances from all 
tests in a single score. This may cause another difficulty, al-
lowing some researchers to lower or increase the proportion 
of POCD, Bodolea C. [35].
Biochemical markers
POCD is currently diagnosed with neuropsychological 
tests, this method being the main assessment tool.
Variability and difficulty in applying neuropsychological 
tests led researchers to look for POCD-specific biochemical 
markers. Determination of specific markers will allow the 
tracking of the evolution and the prevention of this patholo-
gy. Thus, Rasmussen et al. [17], analyses the action of neuron-
specific enolase (NSE) and S-100b protein, both of which are 
early markers in cerebral injuries. Obvious correlations have 
been observed in S-100b plasma levels in abdominal surgery 
and postoperative delirium patients. There was no correla-
tion between POCD and blood concentrations of NSE and 
S-100β protein in abdominal surgery. While in cardiac sur-
gery, namely coronary bypass, the authors had a significant 
increase in both biomarkers at 24 and 48 hours. Except that 
NSE in the statistical analysis correlates with POCD having 
a significant increase at 24 hours postoperatively. While the 
increased plasma concentration of the S-100b protein corre-
lates with the duration of surgery. So NSE seems to be a blood 
marker for early POCD after coronary bypass.
The role of biomarkers in the DCPO predictor such as 
the S-100β protein and the anticholinergic active serum 
(AAS) was evaluated by Plaschke K. et al. [49]. This hy-
pothesis is put by Plaschke on the grounds that AAS has 
previously been described as a risk factor in the appearance 
of the delirium to elderly patients. In contrast to the in-
creased intraoperative plasma concentration of S-100β pro-
tein, the association of AAS with POCD was not detected. 
Nitric oxide is a powerful vasodilator. In the central nervous 
system, nitric oxide functions as a neurotransmitter. The in-
crease in the concentration of nitric oxide and its products, 
nitrites and nitrates, was observed by Molnar T. et al. [51] in 
his paper he aims to evaluate the link between PODC and 
the biomarkers of immuno-endothelial dysfunction, which 
may be linked to ischemia and neurocognitive changes in 
pulmonary onco-surgery. Thus, it analyzes a series of bio-
markers such as soluble P-selectin, soluble ligand, CD40 
as the biomarker of platelet activation, soluble vascular cell 
adhesion molecule-1, MCP-1 (monocyte chemoattractant 
protein-1) Interleukins IL-6, IL-8, C-reactive protein and 
S100B protein. Therefore, the platelet and endothelial-related 
molecules had a preoperative plasma concentration and 48 
hours postoperatively plasma concentration in patients who 
61
62
Gh. Severin. Moldovan Medical Journal. March 2019; 62(1):57-63 REVIEW ARTICLE
developed POCD. Significant increase at 48-hour postopera-
tive was notes for values of MCP-1 and S100B-protein. The 
authors assume that the endothelium and thrombocytes are 
activated as a response to the immune system and the pres-
ence of tumor agents. Translocation of leukocytes with dete-
rioration of the blood-brain barrier and brain ischemia with 
the appearance of POCD occurs after the preoperative acti-
vation of endothelium and platelets. Following the increase 
of these preoperative markers, patients in the risk group who 
may develop POCD could be identified and it is possible to 
even modify therapeutic course, and why not, avoid surgi-
cal intervention in case of risk of the major neurocognitive 
injury of oncological patients.
In 2010, Gaudet et al. [36] comes with an article which 
discusses the correlation between the plasma concentration 
of the marker MMP 9 (matrix metalloproteinase) and POCD 
in patients that undergo endarterectomy. MMP 9 being a 
proteolytic enzyme that acts on the progression and desta-
bilization of atheromatous plaques contributes to damage 
to the blood-brain barrier and contributes to the formation 
of cerebral edema, resulting in cerebral ischemia. Increased 
MMP 9 preoperatively correlated with patients who devel-
oped POCD. There were no increases in postoperative MMP 
9 values. Thus, the authors recommend the use of MMP 9 as 
a predictor of POCD.
Other evaluation methods
Cerebral oximetry is based on Beer-Lambert’s principle, 
where the concentration of a substance can be measured ac-
cording to the degree of light absorption. Regardless of the 
factors that act on the human body in causing cognitive dys-
function, ultimately the brain suffers through hypoxigena-
tion, ischemia, and as a consequence the onset of POCD. 
The variety of studies, were performed in both cardiac and 
non-cardiac surgery. Thus, Murkin J. et al. [52] makes a hy-
pothesis that controlling oxygen concentration in the brain 
during heart surgery by the method of brain oximetry moni-
toring would have beneficial effects on systemic organs. As 
a result, Murkin J. asserts that monitoring and modulating 
intraoperative conduction based on cerebral oximetry values 
in coronary bypass patients avoids profound brain desatura-
tion and is associated with fewer major organ dysfunction. 
However, the given method suffers from some limitations, 
the monitoring of cerebral oximetry does not continue in the 
ICU (intensive care unit), brain oxyge-nation is performed 
on a small part of the brain and may be influenced by ana-
tomic particularity or cerebral edema.
Another study by Slater J. et al. [53], in patients to be op-
erated in cardiac surgery, prolonged intra-operative cerebral 
desaturation has an increased risk of developing POCD and 
prolongs in-hospital stay.
Casati A. et al. [54] in his study uses brain oximetry mon-
itoring in major abdominal surgery in elderly patients. The 
results are to show that intraoperative adjustment of cerebral 
oximetry and avoidance of cerebral desaturation prevents ce-
rebral ischemia in elderly patients, thus preventing the onset 
of POCD and shortens the patient hospital stay, approaching 
the discharge period.
Critical analysis of POCD study methodologies in pub-
lications
In spite of the fact of the years of study in the unraveling of 
POCD, many questions remain unclear. In 2013, Uysal S. and 
Reuch D. [55] confirmed that the difficulty relates to a num-
ber of factors, including very different methods of POCD as-
sessment, and variations in surgical management and surgical 
techniques over time. The sensitivity, specificity, and overall 
usefulness of neurocognitive research methods are well estab-
lished, but the application of these methods to cardiac surgery 
over the past 30 years has often been mistaken.
In 2007, Newman S. et al. [27] comes with a study based 
on investigations of POCD-related publications in non-car-
diac surgery. The authors assert that no study was able to elu-
cidate the possible mechanisms in the occurrence of POCD. 
Research suffers from major shortcomings in the number of 
studies in the field and a number of other technological dif-
ficulties. This includes the high variability of the type of sur-
gery and anesthesia, the number of patients enrolled in the 
study, the diversity of recruitment, the variability of neuro-
psychological tests with different sensitivity, the diversity of 
statistical analysis, and even the variety of application of the 
definition used in the classification of study participants as 
POCD. These differences make it difficult to compare studies 
with each other.
Rasmussen L. et al. [17] asserts that the low frequency 
of POCD in some studies is caused by the incorrect meth-
odology chosen to detect cognitive deviations. Using lower 
threshold tests will not show the presence of POCD correctly. 
Using easy memorable tests will result in underestimations, 
and obtaining the same postoperative outcome in compari-
son with the pre-operative shows certainly that POCD has 
taken place, which many authors do not take into account.
Conclusions
Postoperative cognitive dysfunction is a common compli-
cation after the surgery. It occurs in frail patients or in indi-
viduals presenting general risk factors. It looks like there is a 
genetic predisposition for the development of postoperative 
cognitive dysfunction. Patients at risk of postoperative cogni-
tive dysfunction can be identified by neurocognitive testing 
tools.
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